Abstract
Objective: This study aimed to identify, in the literature, noninvasive measures for prevention of venous ulcer recurrence (VUs). Methods: An integrative review was carried out in the databases of the Biblioteca Virtual em Saúde (BVS), Public Medline (PubMed), Cumulative Index of Nursing and Allied Health Literature (CINAHL) and Excerpta Medica Database (Embase) in the period from 2015 to 2017. the search was performed using the controlled descriptors «varicose ulcer» and «recurrence» and the Boolean operator AND between them in all databases described, in Portuguese, English, and Spanish. After the searches, two reviewers carried out the pre-selection by titles and summary of the articles followed by the full reading of the pre-selected studies. Results: 210 studies were identified, of which 188 were excluded because they did not attend to the guiding question. Two reviewers read in full the 22 pre-selected articles and included in this review nine that were part of the discussion of this paper. Conclusion: Studies in this review suggest that adherence and correct use of compressive therapy with socks associated with education and self-care measures are effective in preventing recurrence of VU. The association of acetylsalicylic acid with standard measures of treatment still lacks conclusive results and new studies to prove efficacy are suggested.
Highlights
venous insu ciency (VUs) has a negative impact on the quality of life (QoL), self-esteem and functionality, causing pain, loss of mobility, withdrawal, and restriction of activities of professional and social life and leisure[4]
A prevalence study conducted in the city of Botucatu, state of São Paulo, with a population of 1,755 patients, found 1.5% of cases of active or healed VU6
The data collection was done by means of a bibliographical survey of publications indexed or cataloged in the portals Biblioteca Virtual em Saúde (BVS) and Public Medline (PubMed) and Cumulative Index of Nursing and Allied Health Literature databases ( CINAHL) and Excerpta Medica Database (Embase) (Fig. 1)
Summary
Ulcers due to venous insu ciency (VUs) account for 75% of chronic ulcers of the lower limbs and a ect approximately 1% of the world population, with an increase in prevalence to 2% in the population over 80 years old, is characterized as a global public health problem[1,2,3,4,5].VU has a negative impact on the quality of life (QoL), self-esteem and functionality, causing pain, loss of mobility, withdrawal, and restriction of activities of professional and social life and leisure[4].e healing rate in six months can vary from 45 to 70%, depending on the evaluation and therapeutic conducts, with a signi cant di erence if performed by specialists or general practitioners. e 12-month relapse rate may range from 26 to 69%. e cost of treating a person with VU is high and varies according to the country›s economic and health structure, ranging from £ 168 to £ 198 million annually in the UK and € 9,569 per client with an ulcer in Germany[5].In Brazil, epidemiological records of prevalence and incidence of VU are still scarce and, to date, there are no official national data. Ulcers due to venous insu ciency (VUs) account for 75% of chronic ulcers of the lower limbs and a ect approximately 1% of the world population, with an increase in prevalence to 2% in the population over 80 years old, is characterized as a global public health problem[1,2,3,4,5]. E healing rate in six months can vary from 45 to 70%, depending on the evaluation and therapeutic conducts, with a signi cant di erence if performed by specialists or general practitioners. E 12-month relapse rate may range from 26 to 69%. A prevalence study conducted in the city of Botucatu, state of São Paulo, with a population of 1,755 patients, found 1.5% of cases of active or healed VU6. We still lack guidelines for the early diagnosis and care of people with chronic venous insufficiency (CVI) and VUs as one of the priority lines of care for chronic diseases in ABS
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
